SG Americas Securities
GMAB icon

SG Americas Securities’s Genmab GMAB Stock Holding History

SG Americas Securities’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
10,217
+1,330
+15% +$35.3K ﹤0.01% 2624
2026
Q1 		$238K Buy
8,887
+2,365
+36% +$70.9K ﹤0.01% 2563
2025
Q4 		$201K Sell
6,522
-473
-7% -$14.7K ﹤0.01% 2929
2025
Q3 		$215K Sell
6,995
-9,319
-57% -$227K ﹤0.01% 2711
2025
Q2 		$337K Sell
16,314
-6,580
-29% -$135K ﹤0.01% 1920
2025
Q1 		$448K Sell
22,894
-3,502
-13% -$73.5K ﹤0.01% 1871
2024
Q4 		$551K Buy
26,396
+11,949
+83% +$263K ﹤0.01% 1242
2024
Q3 		$352K Sell
14,447
-21,787
-60% -$582K ﹤0.01% 1999
2024
Q2 		$911K Buy
36,234
+6,734
+23% +$191K 0.01% 1350
2024
Q1 		$882K Buy
29,500
+23,094
+361% +$678K ﹤0.01% 1179
2023
Q4 		$204K Buy
6,406
+71
+1% +$2.23K ﹤0.01% 2146
2023
Q3 		$223K Hold
6,335
– – ﹤0.01% 2251
2023
Q2 		$241K Sell
6,335
-345
-5% -$13.8K ﹤0.01% 1726
2023
Q1 		$252K Sell
6,680
-23,481
-78% -$903K ﹤0.01% 2249
2022
Q4 		$1.28M Buy
30,161
+23,826
+376% +$982K 0.02% 818
2022
Q3 		$204K Buy
6,335
+285
+5% +$10K ﹤0.01% 2309
2022
Q2 		$197K Hold
6,050
– – ﹤0.01% 2681
2022
Q1 		$219K Buy
6,050
+513
+9% +$17.6K ﹤0.01% 2381
2021
Q4 		$219K Buy
5,537
+1,135
+26% +$47.3K ﹤0.01% 2626
2021
Q3 		$192K Buy
+4,402
New +$198K ﹤0.01% 3258

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SG Americas Securities's GMAB Position: Q2 2026 in Review

SG Americas Securities increased its Genmab (GMAB) stake by 15% in Q2 2026, buying an estimated $35.3K and bringing the position to 10,217 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2624.

SG Americas Securities first reported a position in GMAB in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.28M in Q4 2022. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • SG Americas Securities held 10,217 shares of Genmab worth $281K as of Q2 2026.
  • SG Americas Securities bought 1,330 Genmab shares in Q2 2026, an estimated $35.3K.
  • Genmab made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2624 holding.
  • SG Americas Securities first reported a position in Genmab in Q3 2021 and has held it in 20 quarters since.
  • SG Americas Securities's Genmab position peaked at $1.28M in Q4 2022.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.